Meritage Announces Quarterly Cash Dividend; 33.3% Increase Over Same Period Last Year
Nov 09, 2016 13:00 pm UTC| Business
GRAND RAPIDS, Mich., Nov. 09, 2016 -- Meritage Hospitality Group, Inc. (OTCQX:MHGU), one of the nation’s premier restaurant operators, today announced that the Company’s Board of Directors approved a special quarterly...
Editas Medicine to Present at the Stifel Healthcare Conference 2016
Nov 09, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Nov. 09, 2016 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present a company overview at the Stifel Healthcare Conference 2016 on Wednesday,...
ParkerGale Capital Closes $240 Million Debut Fund
Nov 09, 2016 13:00 pm UTC| Business
CHICAGO, Nov. 09, 2016 -- ParkerGale Capital, LP today announced the close of its debut buyout fund. Exceeding its original target of $200 million, the fund closed at $240 million, with contributions from a balanced mix...
CoLucid Pharmaceuticals Announces 2016 Third Quarter Results and Corporate Highlights
Nov 09, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Nov. 09, 2016 -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD) today reported financial and operating results for the quarter ended September 30, 2016. Corporate Highlights In September 2016 CoLucid...
Genocea to Present at Two Upcoming November Conferences
Nov 09, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Nov. 09, 2016 -- Genocea Biosciences, Inc.(NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that management will present a company...
Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2016 Financial Results
Nov 09, 2016 13:00 pm UTC| Business
WALTHAM, Mass., Nov. 09, 2016 -- Interleukin Genetics, Inc. (OTCQB:ILIU) announced today that it will host a conference call and webcast on Tuesday, November 15, 2016, at 8:30 a.m. Eastern Time to provide a corporate...
Chimerix to Present at Upcoming Investor Conferences
Nov 09, 2016 13:00 pm UTC| Business
DURHAM, N.C., Nov. 09, 2016 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey, M.D., M.P.H, President and Chief...